Eudaimonia Partners, LLC Takeda Pharmaceutical CO LTD Transaction History

Eudaimonia Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$16.55 - $18.64 $7,546 - $8,499	-456 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$16.71 - $19.9 $7,619 - $9,074	456 New	456 $8,000
Q3 2020 Nov 16, 2020	SELL	$17.1 - $19.19 $36,936 - $41,450	-2,160 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $20,674 - $27,631	-1,417 Reduced 39.61%	2,160 $39,000
Q1 2020 May 05, 2020	BUY	$13.02 - $20.31 $46,572 - $72,648	3,577 New	3,577 $54,000

338

76.2M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Eudaimonia Partners, LLC with notifications on news.